Minor Events and the Risk of Deep Venous Thrombosis

Summary

Background Deep venous thrombosis is a common disease, with genetic and acquired risk factors. Many patients have a history of minor events (short periods of immobilisation such as prolonged travel, short illness, minor surgery or injuries) before onset of venous thrombosis. However, the role of these minor events has received little formal study. Also, we do not know how minor events might interact with the presence of genetic prothrombotic defects (factor V Leiden mutation, factor II mutation, protein C, S and antithrombin deficiency). Patients and Methods On the basis of case-control data from a thrombosis service in the Netherlands, we added a follow-up period for a casecross-over analysis of minor events as risk factors, and a case-only analysis for the interaction with factor V Leiden. A total of 187 patients with first, objectively diagnosed venous thrombosis of the legs, aged 15–70, without underlying malignancies and without major acquired risk factors entered the study. For the analysis of minor events in the case-cross-over analysis, we used a matched odds ratio; in the caseonly analysis, we used the multiplicative synergy index. Results In 32.6% of the 187 patients with deep venous thrombosis who did not have major acquired risk factors, minor events were the only external risk factors. Minor events increased the risk of thrombosis about 3-fold, as estimated in the case-cross-over analysis (odds ratio 2.9, 95% confidence interval 1.5–5.4). The synergy index between minor events and factor V Leiden mutation in the case-only analysis was 0.7 (95% confidence interval 0.3–1.5). Therefore, persons with factor V Leiden mutation who experience a minor event will have an estimated risk increase of about 17-fold, which exceeds the sum of the individual risk factors. Conclusions Minor events are likely to play an important role in the development of deep venous thrombosis, especially in the presence of genetic prothrombotic conditions.

Keywords

Venous thromboembolism - epidemiology - travel - immobilisation - risk factors - factor V

• References

• 1 Lane DA, Mannucci PM, Bauer KA, Bertina RM, Bochkov NP, Boulyjenkov V, Chandy M, Dahlbäck B, Ginter EK, Miletich JP, Rosendaal FR, Seligsohn U. Inherited thrombophilia: Part 1. Thromb Haemost 1996; 76: 651-62.
• 2 Houghton A, Taylor P. Vascular hazards of air travel. British J Clin Practice 1993; 47: 60-1.
• 3 Milne R. Venous thromboembolism and travel: is there an association. J R Coll Physicians Lond 1992; 01: 47-9.
• 4 Ferrari E, Chevallier Th, Chapelier A, Baudouy M. Travel as a risk factor for venous thromboembolic disease. Chest 1999; 115: 440-4.
• 5 Koster T, Rosendaal FR, de Ronde H, Briët E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia Study. Lancet 1993; 342: 1503-6.
• 6 Begg CB, Zhang ZF. Statistical analysis of molecular epidemiology studies employing case-series. Cancer Epidemiology, Biomarkers & Prevention 1994; 03: 173-5.
• 7 Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls!. Am J Epidemiol 1996; 144: 207-13.
• 8 Piegorsch WW, Weinberg CR, Taylor JA. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based casecontrol studies. Statistics in Medicine 1994; 13: 153-62.
• 9 Benoit R. Traveller thromboembolic disease: the economy class syndrome. J Mal Vasc 1992; 17: B84-7.
• 10 Beighton PH, Richards PR. Cardiovascular disease in air travellers. Brit Heart J 1968; 30: 367.
• 11 Sarvesvaran R. Sudden natural deaths associated with commercial air travel. Med Sci Law 1986; 26: 35-8.
• 12 Paganin F, Laurent Y, Gauzere BA, Blanc P, Roblin X. Pulmonary embolism on non-stop flights between France and reunion island. Lancet 1996; 347: 1195-6.
• 13 Lederman JA, Keshavarzian A. Acute pulmonary embolism following air travel. Postgr Med J 1983; 59: 104-5.
• 14 Marshall M. Flugreisen-Thrombose. Munch Med Wochenschr 1982; 124: 83.
• 15 Finch P, Ransford R, Hill-Smith A. Thromboembolism and air travel. Lancet 1988; ii: 1025.
• 16 Holliday J. Atypical presentation of multiple pulmonary emboli in a young traveller. J R Coll Gen Pract 1985; 35: 497.
• 17 Homans J. Thrombosis of the deep leg veins due to prolonged sitting. New Engl J Med 1964; 250: 148-9.
• 18 Black J. Deep-vein thrombosis and pulmonary embolism. Lancet 1993; 342: 352-3.
• 19 Cruickshank JM, Gorlin R, Jennett B. Air travel and thrombotic episodes: the economy class syndrome. Lancet 1988; ii: 497-8.
• 20 Kistner RL, Eklof BO, Masuda EM, Sonntag BV, Wong HP. Venous thromboembolism in association with prolonged air travel. Dermatology Surgery 1996; 22: 637-41.
• 21 Simpson K. Shelter deaths from pulmonary embolism. Lancet 1940; 02: 744.
• 22 Steinhauser RP, Stewart JC. Deep venous thrombosis in the military pilot. Aviat Spac Environ 1989; 60: 1096-8.
• 23 Symington IS, Stack BHR. Pulmonary thromboembolism after travel. Br J Dis Chest 1977; 71: 138-40.
• 24 Crane C. Deep venous thrombosis in leg following effort strain. New Engl J Med 1952; 246: 529-33.
• 25 Cairns NJW, Thomas JEP, Abson CP. Pulmonary embolism: a hazard of air travel. Cent Afr J Med 1981; 27: 85-87 1981..
• 26 Burki U. Lungenembolien bei und nach Lang-Streckenflügen (economy class syndrome). Schweiz Med Wochenschrift 1989; 119: 287-9.
• 27 Medler RG, McQueen DA. Effort thrombosis in a young wrestler. J Bone Joint Surgery 1993; 75: 1071-3.
• 28 O’Donnell D. Thromboembolism and air travel. Lancet 1988; ii: 797.
• 29 Mercer A, Brown JD. Venous thromboembolism associated with air travel: a report of 33 patients. Aviation, Space and Environmental. Medicine 1998; 69: 154-7.
• 30 Schambeck C, Schwender S, Haubitz I, Geisen UE, Grossmann RE, Keller F. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?. Thromb Haemost 1997; 78: 1480-3.
• 31 Medicines Adverse Reaction Committee of New Zealand. URL: www.medsafe.govt.nz/hprofs.htm” , go to “Medicines Safety” “Third generation contraceptives and pulmonary embolism”, December 1998 and February 1999.
• 32 WHO Scientific Group. Cardiovascular Disease and Steroid Hormone Contraception. WHO Technical Report Series, 877. WHO. Geneva: 1998
• 33 Walker AM. Newer oral contraceptives and the risk of venous thromboembolism. Contraception 1998; 57: 169-81.